Lybrate.com has a nexus of the most experienced Oncologists in India. You will find Oncologists with more than 38 years of experience on Lybrate.com. Find the best Oncologists online in Hyderabad. View the profile of medical specialists and their reviews from other patients to make an informed decision.
Book Clinic Appointment with Dr. Palanki Satya Dattatreya
Submit a review for Dr. Palanki Satya DattatreyaYour feedback matters!
My father has a tumor in their food pipe. Which is about 25 to 35 cm. Can you please suggest me what can we do.
Sir, my father (77 years) has undergone hydrocele surgery on 29th Nov. After that surgery, he was not able to urinate normally and is now on foley catheter. There had been a urodynamic test also on 27th. Dec. In the report, and during the test, father was not able to void urine, not even a single drop. But he has sensation of urine. He has 34gms of prostate. My question is, if prostate is removed, will it solve the problem? Will he be able to urinate on his own? He is on foley catheter right now. Is size 34gms. Regarded enlarged prostate. Please guide.
Hi I am 34 years old woman, I have 4 big and 4 small epidermal cyst (not sebaceous cyst) on my scalp, duration 3 to 4 years, no pain no other sufferings and movable, so what can I do now ?
According to a major study that provides a connection between height and cancer, taller people are more prone to developing cancer.
Research has found that the risk of developing any kind of cancer in women rises by 18% for an increase of every 10 cm in height. In men, the risk rises by 11%, even though height is not as major a factor as are obesity, smoking and a bad, unhealthy diet.
Several reasons have been put forward for the above statement. One of the reasons is that the number of body cells in taller people is more than people with average height. This leads to an increase in the number of cells which could potentially turn malignant.
While individually analysing the impact of height on different cancer forms, it was found that the highest increase in risk was in skin cancer (30% for every 10 cm increase in height), while a 20% increase was noted in taller women developing breast cancer.
Development of cancer in regions including the colon and rectum is known as colorectal cancer. Long legs have been surprisingly associated with this form of cancer. In comparison with shorter people, it was reported that taller people had a higher risk percentage of developing colorectal cancer. Two hypotheses regarding the formation of colorectal cancer have been developed. One hypothesis is that taller people have longer colons, which in turn result in more surface area where colon cancer can develop. The other hypothesis is that taller people experience increased levels of growth hormones. These particularly affect the length of their legs. The growth hormone called "insulin-like growth factor 1" is increased during puberty and is considered to be a risk factor for colorectal cancers occurring at later stages.
Brain metastases from systemic cancer are the most common type of intracranial neoplasm in adults, being almost 10 times more common than primary malignant brain tumors, which cause a significant burden on the management of patients with advanced cancer (1). The lungs represent one of the most frequent sources of metastases to the brain, with a probability of (36–64%) (3). Symptoms suffered by the patients include headaches, epilepsy, focal weakness, numbness or changes in mental status. The prognosis of patients with brain metastases is not optimistic and the median survival time is ∼1–2 months if left untreated. The 1-year survival rate has been recorded as 10.4% (4,5). The treatment of metastatic brain tumors is complex; not only due to being able to provide local control and improve neurological function, but also due to factors such as age, performance and systemic disease status and the size, volume, location and number of metastases at presentation
CyberKnife is a robotic radiosurgery system with a linear particle accelerator (linac), which is coupled with real-time imaging to track and compensate for the patient’s or target’s motion. As a relatively non-invasive treatment modality, CyberKnife demonstrates certain benefits, including a more accurate target localization and improved dose delivery for the management of metastatic brain tumors that allows higher biologically effective dose delivery without increased incidence of toxicity.
In the present case, the results for the treatment of multiple brain metastases after CyberKnife surgery with a 7–8 Gy marginal dose was promising. CyberKnife for metastatic brain tumors is an effective and safe method for reducing the marginal dose prescribed for multiple brain metastases and for minimizing the radiation-related neurotoxicities. In conclusion, CyberKnife, a focused, highly-targeted radiosurgery and fractionated radiotherapy is particularly useful for multiple brain metastases. CyberKnife provides the advantage of the management of local recurrence and a tolerable complication rate. Although the treatment of brain metastases has been performed with CyberKnife, the clinical significance and optimal dose fractionation scheme require further investigation.
In case you have a concern or query you can always consult an expert & get answers to your questions!